Welcoming you for any type of article submission for the upcoming issue on/before February 26, 2021.

Review Article
Volume 5 Issue 1 - 2020
Differentiated Thyroid Cancer and Radioiodine Therapy After New TNM Staging System
Francesco Lippi* and Antonietta Picone
Thyroid Center Diseases, School of Endocrinology, University of Pisa, Italy
*Corresponding Author: Francesco Lippi, Thyroid Center Diseases, School of Endocrinology, University of Pisa, Italy.
Received: November 25, 2019; Published: December 31, 2019


Differentiated thyroid cancer (DTC) has one of the most frequent diagnosed, especially among women and young adults. The DTC is represented by papillary (90%) and follicular forms (10%) with their multiple variants. The outcomes are generally very good, the recurrence rates are low and survival rates are excellent. Several staging system have been generated to inform DTC management. One of the most widely used is the tumor-nodes-metastasis (TNM) classification elaborated by the American Joint Committee on Cancer (AJCC), which allow to predict the risk of cancer-related death. Recently the 8th edition of the AJCC staging system was published. The main changes with respect to 7th edition are an increase in the age threshold for defining high risk of DC-related death (55 vs 44 years old) and a decrease in the unfavorable prognostic significance for some findings (i.e. microscopic extra-thyroidal extension). Consequently, also the management of DTC after surgery changed, reducing the treatment with radioactive iodine (RAI) adjuvant therapy only for patients with high risks. Some scientists in the world, endocrinologist and nuclear medicine, became to evidence strong differences of opinion about the guidelines recommendations continuing to use RAI adjuvant therapy. To reduce these discrepancies a joint statement was find between the more important four Society in the world to restore trust and confidence and a sense of collegiality between scientists and patients affected. However, there are still authors in the literature who continue to treat patients (except micro carcinoma) still with RIT. About 10 - 15% of patients need an additional dose of RIT to complete the ablation of thyroid residues, while in a small percentage of patients an activity may be present in the pulmonary region (diffuse or nummular type) while still more rare is the manifestation of secondary lesions in the bones or in other organs.

Keywords: Differentiated Thyroid Cancer (DTC); Tumor-Nodes-Metastasis (TNM); Radioactive Iodine (RAI)


  1. Bryan R Haugen., et al. “2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer”. Thyroid 26.1 (2016). 
  2. Hay ID., et al. “Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989”. Surgery 114 (1993): 1050-1057.
  3. Wang TS., et al. “Incidence of metastatic well-differentiated thyroid cancer in cervical lymph nodes”. Archives of Otolaryngology-Head and Neck Surgery 130 (2004): 110-113.
  4. Mazzaferri EL. “An overview of the management of papillary and follicular thyroid carcinoma”. Thyroid 9 (1999): 421-427.
  5. Mazzaferri EL. “Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy”. Endocrine Practice 6 (2000): 469-476.
  6. Cooper DS., et al. “Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry”. Thyroid 8 (1998): 737-744.
  7. Lin JD., et al. “Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation”. American Journal of Clinical Oncology 21 (1998): 77-81.
  8. Brierley JD., et al. “A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example”. Cancer 79 (1997): 2414-2423. 
  9. Hay ID., et al. “Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients”. World Journal of Surgery 26 (2002): 879-885.
  10. Tuttle RM and Leboeuf R. “Follow up approaches in thyroid cancer: a risk adapted paradigm”. Endocrinology and Metabolism Clinics of North America 37 (2008): 419-435, ix-x. 583. 
  11. Schlumberger M., et al. “Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective”. European Journal of Endocrinology 150 (2004): 105-112.
  12. Onitilo AA., et al. “Simplifying the TNM system for clinical use in differentiated thyroid cancer”. Journal of Clinical Oncology 27 (2009): 1872-1878. 
  13. Mankarios D., et al. “Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer”. Endocrine 46 (2013): 300-308.
  14. Orlov S., et al. “Influence of age and primary tumor size on the risk for residual/recurrent well-differentiated thyroid carcinoma”. Head Neck 31 (2009): 782-788.
  15. Vaisman F., et al. “Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy”. Clinical Endocrinology 77 (2012): 132-138.
  16. Cooper DS., et al. “Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer”. Thyroid 19 (2009): 1167-1214.
  17. Tuttle M., et al. “Thyroid differentiated and anaplastic carcinoma (Chapter 73)”. In AJCC Cancer Staging Manual, 8th edition. Eds MB Amin, SB Edge, F Greene, D Byrd, RK Brookland, MK Washington, CC Compton, KR Hess DC, Sullivan, JM Jessup., et al. New York, NY, USA: Springer International Publishing (2017b).
  18. R Michael Tuttle., et al. “Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association”. Thyroid 29.4 (2019).
Citation: Francesco Lippi and Antonietta Picone. “Differentiated Thyroid Cancer and Radioiodine Therapy After New TNM Staging System”. EC Endocrinology and Metabolic Research 5.1 (2020): 01-05.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

March Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the March issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 07, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.